Scott Mager - 31 Aug 2026 Form 3 Insider Report for BIOFORCE NANOSCIENCES HOLDINGS, INC. (BFNH)

Source evidence Original filing metadata and source links for verification. 3 source fields
SEC form
3
Accepted by SEC
03 Sep 2026, 16:04:04 UTC
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Scott Mager

Key filing fact

Scott Mager filed Form 3 for BIOFORCE NANOSCIENCES HOLDINGS, INC. (BFNH) on 03 Sep 2026.

Key facts

  • This page summarizes Scott Mager's Form 3 filing for BIOFORCE NANOSCIENCES HOLDINGS, INC. (BFNH).
  • 0 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 03 Sep 2026, 16:04.

Change

  • No earlier filing in this sequence is available for direct comparison.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reporting Owners (1)

CIK 0002139696 Primary reporting owner

Mager Scott

Relationship
Director
Address
2719 HOLLYWOOD BLVD., SECOND FLOOR, HOLLYWOOD
Signature
/s/ Scott Mager
Signature date
02 Sep 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

BFNH holding

Common Stock; Par Value $0.001

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
1,000,000
Date
31 Aug 2026
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Reporting Person received restricted shares in lieu of cash compensation based on a (3) three service contract with the Company.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .